Average Co-Inventor Count = 8.02
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Array Biopharma Inc. (21 from 329 patents)
2. Sanofi (7 from 1,451 patents)
3. Celgene Car LLC (6 from 44 patents)
4. Genentech, Inc. (1 from 3,221 patents)
5. Celgene Avilomics Research, Inc. (1 from 44 patents)
28 patents:
1. 10774052 - Heteroaryl compounds and uses thereof
2. 10669269 - Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors
3. 10618902 - Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinases
4. 10189794 - Heteroaryl compounds and uses thereof
5. 10065966 - Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinases
6. 9809590 - Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors
7. 9695132 - Heteroaryl compounds and uses thereof
8. 9663524 - Substituted pyrido[2,3-d]pyrimidines as protein kinase inhibitors
9. 9321786 - Heteroaryl compounds and uses thereof
10. 9174981 - Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors
11. 8987251 - Triazolopyridine compounds as PIM kinase inhibitors
12. 8895550 - Triazolopyridine compounds as PIM kinase inhibitors
13. 8841455 - Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as cFMS inhibitors
14. 8680114 - AKT protein kinase inhibitors
15. 8575145 - Triazolopyridine compounds as PIM kinase inhibitors